Skip to main content
. 2021 Feb 24;27(3):136–143. doi: 10.4103/sjg.SJG_266_20

Figure 1.

Figure 1

Pain Severity Score (VAS) in Group A Drotaverine, and Group B Mebeverine on basis of Days